scholarly article | Q13442814 |
P50 | author | Antonio Bertolotto | Q57068828 |
P2093 | author name string | Fabiana Marnetto | |
Marco Capobianco | |||
Simona Malucchi | |||
Alessia Di Sapio | |||
Arianna Sala | |||
Yana Motuzova | |||
P2860 | cites work | Multiple sclerosis following etanercept treatment for ankylosing spondylitis | Q43810403 |
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System. | Q50876825 | ||
CNS demyelination during anti–tumor necrosis factor alpha therapy | Q59758980 | ||
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group | Q78130683 | ||
Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse | Q79255390 | ||
Adalimumab-associated multiple sclerosis | Q79539057 | ||
Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes | Q28219857 | ||
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature | Q30647378 | ||
Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study | Q34501045 | ||
Tumor necrosis factor-alpha antagonists and neuropathy | Q37015624 | ||
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-up. | Q37365418 | ||
Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy | Q37443488 | ||
Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors | Q37911726 | ||
Immune-mediated adverse effects of biologicals used in the treatment of rheumatic diseases | Q37930148 | ||
Demyelination and other neurological adverse events after anti-TNF therapy | Q38137583 | ||
The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion | Q42155690 | ||
P433 | issue | 1 | |
P921 | main subject | cerebrospinal fluid | Q54196 |
P304 | page(s) | 53-60 | |
P577 | publication date | 2015-03-06 | |
P1433 | published in | Neurology and therapy | Q26842826 |
P1476 | title | Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy | |
P478 | volume | 4 |
Search more.